Ocugen Inc Earnings

The next earnings date for Ocugen Inc is November 7, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ocugen Inc Earnings

Report Date	Estimated Earnings Per Share
11/07/2025	$-0.06

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ocugen Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/01/2025	---	$-0.05	16.67%
05/12/2025	Before Market	$-0.05	16.67%
03/31/2025	Before Market	$-0.05	6.19%
11/08/2024	Before Market	$-0.05	0.00%
08/08/2024	Before Market	$-0.04	20.00%
05/14/2024	Before Market	$-0.05	16.67%
02/07/2024	Before Market	$-0.03	50.00%
11/09/2023	Before Market	$-0.06	14.29%
08/21/2023	After Market	$-0.08	-14.29%
05/05/2023	Before Market	$-0.07	36.36%
02/28/2023	Before Market	$-0.10	0.00%
11/08/2022	Before Market	$-0.10	0.00%
08/05/2022	Before Market	$-0.09	-12.50%
05/06/2022	Before Market	$-0.09	-776.69%
02/25/2022	Before Market	$-0.07	-16.67%
11/09/2021	Before Market	$-0.05	-25.00%
08/06/2021	Before Market	$-0.13	-333.33%
05/07/2021	Before Market	$-0.04	-108.00%
03/18/2021	Before Market	$-0.03	-50.00%
11/06/2020	Before Market	$-0.02	0.00%
08/14/2020	Before Market	$-0.19	-375.00%
05/11/2020	Before Market	$-0.07	-40.00%
03/27/2020	Before Market	$4.13	3,050.00%
11/12/2019	After Market	$-3.55	-491.67%
08/09/2019	After Market	$-0.12	-1,100.00%
05/15/2019	After Market	$-4.80	-700.00%
03/22/2019	Before Market	$-6.60	-83.33%
11/08/2018	Before Market	$-14.40	-18.03%
08/09/2018	Before Market	$-7.80	44.29%
05/10/2018	Before Market	$-31.20	-136.36%
03/15/2018	Before Market	$-15.60	3.70%
11/09/2017	Before Market	$-13.80	18.44%
08/10/2017	Before Market	$-15	17.36%
05/11/2017	Before Market	$-16.20	21.74%
03/16/2017	Before Market	$-37.20	-37.78%
11/10/2016	Before Market	$-30.60	-3.55%
08/11/2016	Before Market	$-36.60	-1.24%
05/12/2016	Before Market	$-36	-2.27%
03/10/2016	Before Market	$-36.36	-3.59%
11/12/2015	Before Market	$-36.60	-17.31%
08/12/2015	Before Market	$-34.80	-15.23%
05/14/2015	Before Market	$-36	28.29%
02/26/2015	Before Market	$-4.80	87.88%
12/03/2014	---	$-52.66	---

More About Ocugen Inc

Website

https://www.ocugen.com

Country

USA

Full Time Employees

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.

“Ocugen Inc Earnings” Can Refer to the Ocugen Inc Earnings Date

Some people say “Ocugen Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ocugen Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ocugen Inc Stock on the Earnings Date

If you own Ocugen Inc stock (OCGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ocugen Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ocugen Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ocugen Inc Earnings

You can contact us any time if you would like to ask questions about Ocugen Inc earnings or anything else related to the stock market.